Author： Debruyne Philip R Waldman Scott A Schulz Stephanie
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.7, 2003-07, pp. : 1083-1096
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gastric and gastro-oesophageal cancer therapy
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. :
Access to resources
Recommend
Tamoxifen-treated women at risk for oesophageal or gastric cancer?
Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. :
Breast cancer staging: implications for therapy
Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. :
Gefitinib promising as second-line therapy for oesophageal cancer
Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. :
By Datta Jashodeep Lewis Russell S. Mamtani Ronac Stripp Diana Kelz Rachel R. Drebin Jeffrey A. Fraker Douglas L. Karakousis Giorgos C. Roses Robert E.
Cancer, Vol. 120, Iss. 18, 2014-09 ,pp. :